tiprankstipranks
Advertisement
Advertisement

Check-Cap Files MBody AI Financials as 2026 Merger Target Nears

Story Highlights
  • Check-Cap advances a strategic merger with MBody AI, approved by shareholders in November 2025, to reshape its business profile.
  • The company filed MBody AI’s audited results and combined pro forma data while warning the 2026 merger timeline depends on capital and regulatory approvals.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Check-Cap Files MBody AI Financials as 2026 Merger Target Nears

Claim 55% Off TipRanks

Check-Cap ( (MBAI) ) has shared an update.

On May 12, 2026, Check-Cap reported that its shareholders had approved on November 14, 2025, the planned merger of its wholly owned Nevada subsidiary CC Merger Sub Inc. into MBody AI Corp., with MBody AI to survive as a wholly owned unit. The transaction, governed by a September 12, 2025 merger agreement, is intended to reposition Check-Cap through the consolidation of MBody AI’s operations and technology under its corporate umbrella.

The company said it continues to work toward closing the deal in the first half of 2026 and filed audited financial statements for MBody AI, along with unaudited pro forma combined financial data, to support the process. Management cautioned that completion remains subject to capital availability to meet Nasdaq listing rules as well as regulatory and exchange reviews, meaning the merger’s timing and even consummation remain uncertain for investors and other stakeholders.

Spark’s Take on MBAI Stock

According to Spark, TipRanks’ AI Analyst, MBAI is a Underperform.

Check-Cap’s overall score reflects its significant financial challenges, primarily due to a lack of revenue generation and persistent losses. While the technical analysis hints at possible recovery, the valuation is weak due to negative profitability indicators. The company’s strong equity position is a positive aspect, but without revenue, it faces substantial risks.

To see Spark’s full report on MBAI stock, click here.

More about Check-Cap

Check-Cap Ltd. is an Israel-based medical technology company that operates as a foreign private issuer on U.S. capital markets. The company is pursuing a strategic merger-driven pivot by acquiring Nevada-based MBody AI Corp., which will become a wholly owned subsidiary, signaling a shift in its operational and technological focus.

Average Trading Volume: 87,638

Technical Sentiment Signal: Sell

Current Market Cap: $10.18M

See more data about MBAI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1